Name: Alert - Adverse Late Effects of Cancer Treatment: Volume 1: General Concepts and Specific Precepts (Medical Radiology) (en Inglés)
Price: 160320.00 CLP
Availability: InStock
Author: Rubin Philip|Constine Louis S.|Marks Lawrence B.
ISBN: 9783662501344

portada Alert - Adverse Late Effects of Cancer Treatment: Volume 1: General Concepts and Specific Precepts (Medical Radiology) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Rubin Philip|Constine Louis S.|Marks Lawrence B.

Idioma

Inglés

N° páginas

311

Encuadernación

Tapa Blanda

ISBN13

9783662501344

N° edición

Alert - Adverse Late Effects of Cancer Treatment: Volume 1: General Concepts and Specific Precepts (Medical Radiology) (en Inglés)

Rubin Philip|Constine Louis S.|Marks Lawrence B. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 160.320

$ 320.630

Ahorras: $ 160.310

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 27 de Junio y el Viernes 05 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Alert - Adverse Late Effects of Cancer Treatment: Volume 1: General Concepts and Specific Precepts (Medical Radiology) (en Inglés)"

The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of "ALERT - Adverse Late Effects of Cancer Treatment" is to offer a coherent multidisciplinary approach to the care of cancer survivors. The Volume focuses on the general concepts and principles relevant to late effects and on the dynamic interplay of molecular, cytologic and histopathologic events that lead to altered physiologic and metabolic functions and their clinical manifestations. Chapters are also included on legal issues, economic aspects, nursing, psychological issues and quality of life. It is anticipated that this textbook will become the gold standard in providing information on the late effects of cancer treatment and that, in its digitized form, it will be referenced in cancer survivorship guidelines.